PFCS
CGEM icon

Pale Fire Capital SE’s Cullinan Oncology CGEM Stock Holding History

Pale Fire Capital SE’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Sell
14,218
-5,100
-26% -$65.5K 0.02% 53
2025
Q4 		$200K Buy
19,318
+4,703
+32% +$42.4K 0.01% 51
2025
Q3 		$86.7K Buy
+14,615
New +$107K 0.01% 52

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Pale Fire Capital SE's CGEM Position: Q1 2026 in Review

Pale Fire Capital SE reduced its Cullinan Oncology (CGEM) stake by 26% in Q1 2026, selling an estimated $65.5K and leaving 14,218 shares worth $202K. The position accounts for 0.02% of the portfolio, ranked #53.

Pale Fire Capital SE first reported a position in CGEM in Q3 2025 and has held it in 3 quarters since. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Pale Fire Capital SE held 14,218 shares of Cullinan Oncology worth $202K as of Q1 2026.
  • Pale Fire Capital SE sold 5,100 Cullinan Oncology shares in Q1 2026, an estimated $65.5K.
  • Cullinan Oncology made up 0.02% of Pale Fire Capital SE's portfolio in Q1 2026, its #53 holding.
  • Pale Fire Capital SE first reported a position in Cullinan Oncology in Q3 2025 and has held it in 3 quarters since.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.